Literature DB >> 27251056

Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients.

Felix Haglund1,2, Stina Garvin3, Catharina Ihre-Lundgren4, Inga-Lena Nilsson4, Evelina Hall5, Tobias Carling6, Anders Höög7,5, C Christofer Juhlin8,9.   

Abstract

Papillary thyroid carcinoma (PTC) is a common endocrine malignancy, frequently presenting with lymph node metastasis at the time of diagnosis. Lymph node staging (N) partly determines treatment, follow-up, and prognosis. Since 2011, our institution has employed a more comprehensive histopathological work-up of lymph nodes in patients with PTC. We sought to retrospectively determine the value of serial lymph node level sectioning in PTCs with negative preoperative lymph node status (pN0) as a method to increase the sensitivity of detecting metastatic disease. We included all patients that underwent thyroidectomy and central neck dissection and subsequent comprehensive lymph node level sectioning due to PTC with an initial pN0 status between the years 2011 and 2015 at our institution. Sixty-seven cases of PTC with a median of 10 metastatic free lymph nodes identified per case were included. After serial lymph node sectioning of the central compartment, 11 cases (16 %) revealed lymph node metastasis, six of which (55 %) presented with a small primary tumor (<20 mm, T1). Of all T1 tumors with initial pN0 status, 18 % (T1a) and 9 % (T1b) reached a pN1 stage after comprehensive lymph node sectioning. Cases with altered lymph node status had a median of 15 identified lymph nodes as compared to ten in cases that remained negative. We conclude that comprehensive lymph node sectioning increased the sensitivity of detecting metastases in PTC and altered the pathological TNM staging (pTNM) for a significant number of patients. Although of limited prognostic significance, the method should be considered as an adjunct tool when assessing lymph node status of PTC as a part of the routine histological work-up to ensure an accurate cancer staging.

Entities:  

Keywords:  Level sectioning; Lymph node staging; Papillary thyroid carcinoma; Pathology; TNM

Mesh:

Year:  2016        PMID: 27251056     DOI: 10.1007/s12022-016-9438-3

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  15 in total

Review 1.  Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma.

Authors:  Tobias Carling; Sally E Carty; Maria M Ciarleglio; David S Cooper; Gerard M Doherty; Lawrence T Kim; Richard T Kloos; Ernest L Mazzaferri; Peter N Peduzzi; Sanziana A Roman; Rebecca S Sippel; Julie A Sosa; Brendan C Stack; David L Steward; Ralph P Tufano; R Michael Tuttle; Robert Udelsman
Journal:  Thyroid       Date:  2012-02-07       Impact factor: 6.568

3.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

4.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

Review 5.  Papillary thyroid carcinoma: an update.

Authors:  Virginia A LiVolsi
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

6.  The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.

Authors:  Victor Zaydfudim; Irene D Feurer; Marie R Griffin; John E Phay
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

7.  Lymph node surgery in papillary thyroid carcinoma.

Authors:  Ernst Gemsenjäger; Aurel Perren; Burkhardt Seifert; Georges Schüler; Ingrid Schweizer; Philipp U Heitz
Journal:  J Am Coll Surg       Date:  2003-08       Impact factor: 6.113

8.  Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry.

Authors:  H A Gietema; R J C L M Vuylsteke; I A de Jonge; P A M van Leeuwen; B G Molenkamp; J R M van der Sijp; S Meijer; P J van Diest
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

9.  Risk factor analysis for central nodal metastasis in papillary thyroid carcinoma.

Authors:  Ling-Na Mao; Ping Wang; Zhi-Yu Li; Yong Wang; Zheng-Ya Song
Journal:  Oncol Lett       Date:  2014-11-04       Impact factor: 2.967

10.  Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma.

Authors:  Brian Hung-Hin Lang; Alex H Tang; Kai Pun Wong; Tony W Shek; Koon Yat Wan; Chung-Yau Lo
Journal:  Ann Surg Oncol       Date:  2012-05-08       Impact factor: 5.344

View more
  3 in total

1.  Positive Lymph Node Counts in American Thyroid Association Low-Risk Papillary Thyroid Carcinoma Patients.

Authors:  Martha J Griffin; Fred M Baik; Margaret Brandwein-Weber; Muhammad Qazi; Lauren E Yue; Marcela Osorio; Mark L Urken
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

2.  The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma.

Authors:  Jia-Qian Hu; Duo Wen; Ben Ma; Ting-Ting Zhang; Tian Liao; Xiao Shi; Yu-Long Wang; Yong-Xue Zhu; Yu Wang; Wen-Jun Wei; Qing-Hai Ji
Journal:  Cancer Med       Date:  2019-12-18       Impact factor: 4.452

3.  Isthmic Papillary Thyroid Carcinoma Presents a Unique Pattern of Central Lymph Node Metastasis.

Authors:  Liguang Zhou; Chao Gao; Haipeng Li; Weili Liang; Qingdong Zeng; Bo Chen
Journal:  Cancer Manag Res       Date:  2020-05-19       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.